The starting material
01Whole plant extracts
Biological complexity. Composition and consistency vary with each batch.
Swiss bioactive technology
Biological activity.
Precisely rebuilt.
We identify what works in nature, understand the molecular system behind it and reconstruct it with precision. For the next generation of Cannabinoid actives for skin and topical applications with no batch-to-batch variation.
01 / A different starting point
Nature is complex.
Precision is a choice.
Natural extracts can vary in composition. Isolated molecules offer definition, but may not retain the activity of a broader molecular system. Dinetic AG built the third option: selected molecules, combined in a defined ratio.
The isolated approach
02Single molecules
A precisely defined component. Exact and reproducible. But one molecule reaches one point in a system that has many.
The Dinetic approach
03Defined bioactive systems
Selected molecules, assembled from pure isolates in a fixed ratio. The complexity of an extract with the precision of an isolate. The same composition every time.
02 / Activity comes first
Follow the biology.
Then engineer the system.
We start with measured activity, not with a hyped up molecule. Over five years we screened more than 100 molecule combinations across more than 200 extraction protocols from various promising medicinal plants. The activity came first; the composition was engineered backwards.
Screen
More than 200 extraction protocols from promising medicinal plants were screened and combinations of active ingredients were tested for biological activity in cell models.
Identify
Establish which actives had the highest effects in cell models and what combinations and ratios produced the best response.
Reconstruct
Rebuild the active combination from pure isolates rather than from plant material. This is Fraktion8.
Validate
Cell-model and topical human-in-use evaluation, each answering a different question.
Deliver
Encapsulation in a nanoemulsion carrier to increase delivery and penetration. Efficacy of the combined system under evaluation.
03 / From composition to application
Precision.
Beneath the surface.
Discover how Fraktion8 and nanoemulsion come together.
The ratio makes the difference.
Selected molecules. A defined ratio. Developed to work together.
The composition is the know-how.
Research. In a precise form.
The defined combination becomes Fraktion8: a reproducible active complex in powder form.
Defined. Reproducible. Ready to formulate.
Small droplets. New possibilities.
Fraktion8 is incorporated into nanoemulsion droplets, transforming the powder into a finely dispersed active formulation.
Active and delivery. Designed together.
Developed for skin contact.
Nanoemulsions can improve the delivery of lipophilic actives to the skin. We use this formulation approach for Fraktion8.
Delivery technology with a scientific foundation.
One complex. Multiple skin needs.
- Supports the skin barrier
- Soothes the skin
- Reduces redness and irritation
- Hydrates the skin
Scientific context
Molecule symbols reveal neither chemical structures nor the confidential formula. Droplet size, skin distribution and release are schematic. Droplet entry and enhanced skin penetration illustrate the technology concept.
04 / From technology to market
One technology foundation.
Two commercial pathways.
Licensing Fraktion8 to brands is the business. Formula51, our own skincare brand, is how we prove the ingredient works in a finished product, and how we learn things a pure ingredient supplier never sees.
Strategic ingredient partnerships
01Partner applications
A European market leader in topical muscle and joint care has signed a licensing contract for Fraktion8 and is building its next product around it. Partners get the active, the delivery system and the technical dossier. They keep the formulation, the registration and the customer. The product is in development and not yet on the shelf.
Consumer product / Formula51 / Premium skincare
02Our own brand
Formula51 is a premium skincare brand built around Fraktion8 as its lead active. Production in Switzerland is ready and the brand is registered; it has not launched yet. It exists so a partner can see the ingredient working in a finished product.
05 / The next chapter
From a first bioactive system
to a scalable business.
The discovery work is behind us: five years of research, funded by the founders. What comes next is commercial: completing the evidence on Fraktion8 + nanoemulsion, signing the next licensing partners, and bringing Formula51 to market. We are raising a seed round to fund that phase.